Back to results
US 9,150,523 B2Granted
Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
AssigneeMetabolys
InventorsGerard Moinet, Gabriel Baverel, Remi Nazaret, Bernard Ferrier
Life of this patent
Estimating the term…
Abstract
Disclosed herein are compounds and compositions useful in the treatment of pathologies associated with the insulin resistance syndrome (or syndrome X), in particular in the treatment of type 2 diabetes.
Claims6
A compound of formula (I),
- in which:
- R1 is —(CH2)4C(O)OH;
- and;
- R2 represents:
- a phenyl, non-substituted or substituted by one or more substituents, identical or different, chosen from:
- a C1 to C6 alkoxy group, linear or branched;
- a halogen atom;
- or
- a C1 to C5 alkyl group, linear or branched, substituted by one or more halogen atoms;
- a monocyclic or polycyclic heteroaryl chosen from
7 more elements
Dependencies are inferred from the claim text.